evotaz

Generic: atazanavir and cobicistat

Labeler: e.r. squibb & sons, l.l.c.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name evotaz
Generic Name atazanavir and cobicistat
Labeler e.r. squibb & sons, l.l.c.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

atazanavir sulfate 300 mg/1, cobicistat 150 mg/1

Manufacturer
E.R. Squibb & Sons, L.L.C.

Identifiers & Regulatory

Product NDC 0003-3641
Product ID 0003-3641_fa642c67-5a9e-4136-a141-64e1236f6a0f
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA206353
Listing Expiration 2026-12-31
Marketing Start 2015-01-29

Pharmacologic Class

Established (EPC)
cytochrome p450 3a inhibitor [epc]
Mechanism of Action
cytochrome p450 3a inhibitors [moa] p-glycoprotein inhibitors [moa] cytochrome p450 2d6 inhibitors [moa] organic anion transporting polypeptide 1b1 inhibitors [moa] organic anion transporting polypeptide 1b3 inhibitors [moa] breast cancer resistance protein inhibitors [moa] multidrug and toxin extrusion transporter 1 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00033641
Hyphenated Format 0003-3641

Supplemental Identifiers

RxCUI
1601654 1601660
UNII
4MT4VIE29P LW2E03M5PG
NUI
N0000190114 N0000191001 N0000185503 N0000182137 N0000190107 N0000190108 N0000190113 N0000191423

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name evotaz (source: ndc)
Generic Name atazanavir and cobicistat (source: ndc)
Application Number NDA206353 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 300 mg/1
  • 150 mg/1
source: ndc
Packaging
  • 30 TABLET in 1 BOTTLE (0003-3641-11)
source: ndc

Packages (1)

0003-3641-11 30 TABLET in 1 BOTTLE (0003-3641-11)

Ingredients (2)

atazanavir sulfate (300 mg/1) cobicistat (150 mg/1)

Linked Drug Pages (1)

EVOTAZ ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "fa642c67-5a9e-4136-a141-64e1236f6a0f", "openfda": {"nui": ["N0000190114", "N0000191001", "N0000185503", "N0000182137", "N0000190107", "N0000190108", "N0000190113", "N0000191423"], "unii": ["4MT4VIE29P", "LW2E03M5PG"], "rxcui": ["1601654", "1601660"], "spl_set_id": ["83db29d7-5d85-49d6-8cb6-740473365cf8"], "pharm_class_epc": ["Cytochrome P450 3A Inhibitor [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]", "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]", "Breast Cancer Resistance Protein Inhibitors [MoA]", "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]"], "manufacturer_name": ["E.R. Squibb & Sons, L.L.C."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (0003-3641-11)", "package_ndc": "0003-3641-11", "marketing_start_date": "20150129"}], "brand_name": "EVOTAZ", "product_id": "0003-3641_fa642c67-5a9e-4136-a141-64e1236f6a0f", "dosage_form": "TABLET", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitor [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "HIV Protease Inhibitors [MoA]", "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]", "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]", "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Protease Inhibitor [EPC]", "UDP Glucuronosyltransferases Inhibitors [MoA]", "UGT1A1 Inhibitors [MoA]"], "product_ndc": "0003-3641", "generic_name": "atazanavir and cobicistat", "labeler_name": "E.R. Squibb & Sons, L.L.C.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "EVOTAZ", "active_ingredients": [{"name": "ATAZANAVIR SULFATE", "strength": "300 mg/1"}, {"name": "COBICISTAT", "strength": "150 mg/1"}], "application_number": "NDA206353", "marketing_category": "NDA", "marketing_start_date": "20150129", "listing_expiration_date": "20261231"}